{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:38:31Z","timestamp":1789609111966,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T00:00:00Z","timestamp":1735171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ekir.2024.12.031","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T07:49:36Z","timestamp":1735544976000},"page":"828-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation"],"prefix":"10.1016","volume":"10","author":[{"given":"Dominique","family":"Bertrand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Del Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Sberro Soussan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Caillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Claisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Couzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Hertig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yannick","family":"Le Meur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Pernin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coralie","family":"Poulain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9dric","family":"Rafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Matignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Buteux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Fran\u00e7ois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Lemoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Laurent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nassim","family":"Kamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tristan","family":"de Nattes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Guerrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2024.12.031_bib1","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/ajt.13502","article-title":"ABO-incompatible living kidney transplants: evolution of outcomes and immunosuppressive management","volume":"16","author":"Okumi","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib2","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.2215\/CJN.00540118","article-title":"ABO-incompatible kidney transplant outcomes: A meta-analysis","volume":"13","author":"de Weerd","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.12.031_bib3","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(18)32091-9","article-title":"Clinical outcomes after ABO-incompatible renal transplantation: a systematic review and meta-analysis","volume":"393","author":"Scurt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2024.12.031_bib4","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1053\/j.ajkd.2020.03.029","article-title":"Impact of ABO-incompatible living donor kidney transplantation on patient survival","volume":"76","author":"Massie","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.ekir.2024.12.031_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/TP.0b013e318245b2af","article-title":"Outcomes of ABO-incompatible kidney transplantation in the United States","volume":"93","author":"Montgomery","year":"2012","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.031_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/TP.0000000000000312","article-title":"Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.031_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/tri.12234","article-title":"Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation","volume":"27","author":"Barnett","year":"2014","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2024.12.031_bib8","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.tp.0000173647.43616.78","article-title":"Lack of correlation between results of ABO-incompatible living kidney transplantation and anti-ABO blood type antibody titers under our current immunosuppression","volume":"80","author":"Shimmura","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.031_bib9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1111\/ajt.13256","article-title":"ABOi with conventional immunosuppression alone-antiblood group antibody isn\u2019t the only contributor to antibody-mediated rejection and\/or thrombotic microangiopathy","volume":"15","author":"Cohney","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib10","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.ajt.2024.01.029","article-title":"De novo thrombotic microangiopathy after kidney transplantation in adults: interplay between complement genetics and multiple endothelial injury","volume":"24","author":"Dessaix","year":"2024","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib11","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1111\/j.1600-6143.2010.03178.x","article-title":"De novo thrombotic microangiopathy in renal allograft biopsies-role of antibody-mediated rejection","volume":"10","author":"Satoskar","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ajt.2023.10.016","article-title":"The Banff 2022 Kidney Meeting Report: Reappraisal of microvascular inflammation and the role of biopsy-based transcript diagnostics","volume":"24","author":"Naesens","year":"2024","journal-title":"Am J Transplant. Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1600-6135.2003.00278.x","article-title":"Histologic findings of antibody-mediated rejection in ABO blood-group-incompatible living-donor kidney transplantation","volume":"4","author":"Fidler","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib14","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1111\/iju.14118","article-title":"Analysis of the prevalence of systemic de novo thrombotic microangiopathy after ABO-incompatible kidney transplantation and the associated risk factors","volume":"26","author":"Tasaki","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.ekir.2024.12.031_bib15","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A\u00a0more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ekir.2024.12.031_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2215\/CJN.0000000000000100","article-title":"A\u00a0simple molecular tool for the assessment of kidney transplant biopsies","volume":"18","author":"de Nattes","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.ekir.2024.12.031_bib18","doi-asserted-by":"crossref","first-page":"755","DOI":"10.12659\/AOT.900915","article-title":"Increased incidence of thrombotic microangiopathy after ABO-incompatible living donor liver transplantation","volume":"21","author":"Kishida","year":"2016","journal-title":"Ann Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib19","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/j.1600-6143.2008.02538.x","article-title":"Acute antibody-mediated rejection in living ABO-incompatible kidney transplantation: long-term impact and risk factors","volume":"9","author":"Toki","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib20","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/j.1600-6143.2010.03103.x","article-title":"ABO antibody titer and risk of antibody-mediated rejection in ABO-incompatible renal transplantation","volume":"10","author":"Tobian","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib21","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1097\/TP.0000000000001403","article-title":"Evaluation of microvascular inflammation in ABO-incompatible kidney transplantation","volume":"101","author":"Ishihara","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.031_bib22","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1111\/ajt.16712","article-title":"Characterization of ABH-subtype donor-specific antibodies in ABO-A-incompatible kidney transplantation","volume":"21","author":"Bentall","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib23","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1111\/ajt.12920","article-title":"ABO incompatible renal transplantation without antibody removal using conventional immunosuppression alone","volume":"14","author":"Masterson","year":"2014","journal-title":"Am J Transplant"},{"issue":"12 suppl","key":"10.1016\/j.ekir.2024.12.031_bib24","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.tp.0000296646.17845.12","article-title":"Flow cytometric measurement of ABO antibodies in ABO-incompatible living donor kidney transplantation","volume":"84","author":"Yung","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.ekir.2024.12.031_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10248","article-title":"A\u00a0novel method of CD31-combined ABO carbohydrate antigen microarray predicts acute antibody-mediated rejection in ABO-incompatible kidney transplantation","volume":"35","author":"Tasaki","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/j.ekir.2024.12.031_bib26","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.transproceed.2019.01.128","article-title":"Detection of intragraft anti-blood Group A and B antibodies following renal transplantation","volume":"51","author":"Nakamura","year":"2019","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ekir.2024.12.031_bib27","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib28","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1111\/ajt.15397","article-title":"Safety and efficacy of eculizumab for the prevention of antibody-mediated rejection after deceased-donor kidney transplantation in patients with preformed donor-specific antibodies","volume":"19","author":"Glotz","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib29","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1111\/ajt.15364","article-title":"Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial","volume":"19","author":"Marks","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib30","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/ajt.13168","article-title":"Positive crossmatch kidney transplant recipients treated with eculizumab: outcomes beyond 1 year","volume":"15","author":"Cornell","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib32","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1111\/j.1432-2277.2011.01290.x","article-title":"Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation","volume":"24","author":"Biglarnia","year":"2011","journal-title":"Transpl Int"},{"issue":"suppl 1","key":"10.1016\/j.ekir.2024.12.031_bib33","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/nep.12768","article-title":"Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab","volume":"21","author":"Ikeda","year":"2016","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.ekir.2024.12.031_bib34","article-title":"Eculizumab for thrombotic microangiopathy associated with antibody-mediated rejection after ABO-incompatible kidney transplantation","volume":"2017","author":"Lanfranco","year":"2017","journal-title":"Case Rep Transplant"},{"key":"10.1016\/j.ekir.2024.12.031_bib35","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/trf.13119","article-title":"Eculizumab inhibits hemolysis in a model of ABO-incompatible red blood cell transfusion","volume":"55","author":"Fata","year":"2015","journal-title":"Transfusion"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924034776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024924034776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T08:33:07Z","timestamp":1744878787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024924034776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2468024924034776"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2024.12.031","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Thrombotic Microangiopathy After ABO-Incompatible Living Donor Kidney Transplantation","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2024.12.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier, Inc., on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}